Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7000326 | 0.90 | PTGS2 (0.49) | PTGS2PTGS1 | |
| SCHEMBL7001779 | 0.88 | PTGS2 (0.54) | PTGS2PTGS1 | |
| SCHEMBL6993993 | 0.88 | PTGS2 (0.53) | PTGS2PTGS1 | |
| SCHEMBL6994581 | 0.87 | PTGS2 (0.53) | PTGS2PTGS1 | |
| SCHEMBL6996596 | 0.87 | PTGS2 (0.42) | PTGS2PTGS1 | |
| SCHEMBL7001154 | 0.86 | PTGS2 (0.43) | PTGS2PTGS1 | |
| SCHEMBL6999807 | 0.86 | PTGS2 (0.53) | PTGS2PTGS1 | |
| SCHEMBL6997781 | 0.86 | PTGS2 (0.56) | PTGS2PTGS1 | |
| SCHEMBL6995304 | 0.85 | PTGS2 (0.41) | PTGS2PTGS1 | |
| SCHEMBL6994444 | 0.85 | PTGS2 (0.45) | PTGS2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1109799-B1 | 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS | PACIFIC CORP (KR) | 2003-12-17 | — | — | EP | claimed |
| US-6492416-B1 | TREATING INFLAMMATION AND ASSOCIATED DISORDERS | PACIFIC CORPORATION (KR) | 2002-12-10 | — | — | US | claimed |
| EP-1109799-A1 | 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS | PACIFIC CORPORATION (KR) | 2001-06-27 | — | — | EP | claimed |
| WO-2000061571-A1 | 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS | PACIFIC CORPORATION (KR) | 2000-10-19 | — | — | WO | claimed |
| EP-1109799-B1 | 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS | PACIFIC CORP (KR) | 2003-12-17 | — | — | EP | disclosed |
| US-6492416-B1 | TREATING INFLAMMATION AND ASSOCIATED DISORDERS | PACIFIC CORPORATION (KR) | 2002-12-10 | — | — | US | disclosed |